StemRIM (TYO:4599)
Japan · Delayed Price · Currency is JPY 300.00
+3.00 (1.01%)
At close: Mar 6, 2026
StemRIM Market Cap
StemRIM has a market cap or net worth of 18.8 billion as of March 6, 2026. Its market cap has decreased by -3.93% in one year.
Market Cap
18.80B
Enterprise Value
12.42B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
300.00
Market Cap Chart
Since August 9, 2019, StemRIM's market cap has decreased from 49.82B to 18.80B, a decrease of -62.25%. That is a compound annual growth rate of -13.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 18.80B | 14.07% |
| Dec 30, 2025 | 16.49B | -15.37% |
| Dec 30, 2024 | 19.48B | -45.16% |
| Dec 29, 2023 | 35.52B | -34.08% |
| Dec 30, 2022 | 53.89B | 3.59% |
| Dec 30, 2021 | 52.02B | 40.86% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Renascience | 25.23B |
| AnGes | 22.16B |
| RaQualia Pharma | 21.75B |
| ReproCELL | 16.00B |
| Kubota Pharmaceutical Holdings | 15.12B |
| Stella Pharma | 14.97B |
| CanBas | 14.41B |
| Immuno-Biological Laboratories | 14.24B |